Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings
- PMID: 17675595
- DOI: 10.1044/1092-4388(2007/064)
Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings
Erratum in
- J Speech Lang Hear Res. 2007 Dec;50(6):1652
Abstract
Purpose: To evaluate the effects of intensive voice treatment targeting vocal loudness (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson's disease (PD).
Method: A group of individuals with PD receiving LSVT (n = 14) was compared to a group of individuals with PD not receiving LSVT (n = 15) and a group of age-matched healthy individuals (n = 14) on the variables vocal sound pressure level (VocSPL); various measures of the first (F1) and second (F2) formants of the vowels /i/, /u/, and /a/; vowel triangle area; and perceptual vowel ratings. The vowels were extracted from the words key, stew, and Bobby embedded in phrases. Perceptual vowel rating was performed by trained raters using a visual analog scale.
Results: Only VocSPL, F2 of the vowel /u/ (F2u), and the ratio F2i/F2u significantly differed between patients and healthy individuals pretreatment. These variables, along with perceptual vowel ratings, significantly changed (improved) in the group receiving LSVT only.
Conclusion: These results, along with previous findings, add further support to the generalized therapeutic impact of intensive voice treatment on orofacial functions (speech, swallowing, facial expression) and respiratory and laryngeal functions in individuals with PD.
Similar articles
-
Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.Clin Linguist Phon. 2015 Jun;29(6):424-40. doi: 10.3109/02699206.2015.1012301. Epub 2015 Feb 17. Clin Linguist Phon. 2015. PMID: 25688915
-
Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria.Int J Speech Lang Pathol. 2010 Jun;12(3):203-20. doi: 10.3109/17549500903568468. Int J Speech Lang Pathol. 2010. PMID: 20433339 Clinical Trial.
-
Intensive treatment of dysarthria secondary to stroke.Clin Linguist Phon. 2012 Aug;26(8):681-94. doi: 10.3109/02699206.2012.696173. Clin Linguist Phon. 2012. PMID: 22774928
-
The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders.Semin Speech Lang. 2006 Nov;27(4):283-99. doi: 10.1055/s-2006-955118. Semin Speech Lang. 2006. PMID: 17117354 Review.
-
Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.Semin Speech Lang. 2004 May;25(2):169-80. doi: 10.1055/s-2004-825653. Semin Speech Lang. 2004. PMID: 15118943 Review.
Cited by
-
Effect of dopaminergic medication on speech dysfluency in Parkinson's disease: a longitudinal study.J Neural Transm (Vienna). 2015 Aug;122(8):1135-42. doi: 10.1007/s00702-015-1363-y. Epub 2015 Jan 13. J Neural Transm (Vienna). 2015. PMID: 25583417
-
Sex Differences in the Speech of Persons With and Without Parkinson's Disease.Am J Speech Lang Pathol. 2024 Jan 3;33(1):96-116. doi: 10.1044/2023_AJSLP-22-00350. Epub 2023 Oct 27. Am J Speech Lang Pathol. 2024. PMID: 37889201 Free PMC article.
-
Physical, occupational, speech and swallowing therapies and physical exercise in Parkinson's disease.J Neural Transm (Vienna). 2011 May;118(5):773-81. doi: 10.1007/s00702-011-0622-9. Epub 2011 Apr 3. J Neural Transm (Vienna). 2011. PMID: 21461962 Review.
-
Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus.J Commun Disord. 2011 Nov-Dec;44(6):688-700. doi: 10.1016/j.jcomdis.2011.05.003. Epub 2011 Jun 13. J Commun Disord. 2011. PMID: 21724193 Free PMC article. Clinical Trial.
-
Continuous theta burst stimulation over right cerebellum for speech impairment in Parkinson's disease: study protocol for a randomized, sham-controlled, clinical trial.Front Aging Neurosci. 2023 Aug 15;15:1215330. doi: 10.3389/fnagi.2023.1215330. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37655339 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous